Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Pediatrix Medical Group Inc’s stock clocked out at $22.12, down -0.76% from its previous closing price of $22.29. In other words, the price has decreased by -$0.76 from its previous closing price. On the day, 0.75 million shares were traded. MD stock price reached its highest trading level at $22.59 during the session, while it also had its lowest trading level at $21.98.
Ratios:
To gain a deeper understanding of MD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.95. For the most recent quarter (mrq), Quick Ratio is recorded 1.83 and its Current Ratio is at 1.83. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.68.
On September 26, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $14.
Deutsche Bank Upgraded its Sell to Hold on June 07, 2024, while the target price for the stock was maintained at $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 17 ’25 when Rucker Michael A. sold 10,478 shares for $23.00 per share. The transaction valued at 240,994 led to the insider holds 59,101 shares of the business.
Rucker Michael A. bought 10,478 shares of MD for $240,994 on Nov 17 ’25. On Nov 06 ’25, another insider, Linynsky Laura A, who serves as the Director of the company, sold 10,000 shares for $21.65 each. As a result, the insider received 216,500 and left with 32,232 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 1926302464 and an Enterprise Value of 2041252352. As of this moment, Pediatrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.68, and their Forward P/E ratio for the next fiscal year is 10.12. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.77. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.99 while its Price-to-Book (P/B) ratio in mrq is 2.13. Its current Enterprise Value per Revenue stands at 1.062 whereas that against EBITDA is 7.925.
Stock Price History:
The Beta on a monthly basis for MD is 0.73, which has changed by 0.54469275 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, MD has reached a high of $24.99, while it has fallen to a 52-week low of $11.84. The 50-Day Moving Average of the stock is 11.88%, while the 200-Day Moving Average is calculated to be 40.84%.
Shares Statistics:
It appears that MD traded 921.08K shares on average per day over the past three months and 1190550 shares per day over the past ten days. A total of 85.83M shares are outstanding, with a floating share count of 84.39M. Insiders hold about 1.73% of the company’s shares, while institutions hold 95.48% stake in the company. Shares short for MD as of 1763078400 were 2919400 with a Short Ratio of 3.17, compared to 1760486400 on 2746734. Therefore, it implies a Short% of Shares Outstanding of 2919400 and a Short% of Float of 4.78.
Earnings Estimates
The dynamic stock of Pediatrix Medical Group Inc (MD) is currently attracting attention from 7.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.38, with high estimates of $0.41 and low estimates of $0.36.
Analysts are recommending an EPS of between $2.16 and $2.05 for the fiscal current year, implying an average EPS of $2.08. EPS for the following year is $2.19, with 7.0 analysts recommending between $2.39 and $2.11.
Revenue Estimates
In. The current quarter, 7 analysts expect revenue to total $486.23M. It ranges from a high estimate of $521.66M to a low estimate of $465.47M. As of. The current estimate, Pediatrix Medical Group Inc’s year-ago sales were $502.36MFor the next quarter, 7 analysts are estimating revenue of $473.79M. There is a high estimate of $479.8M for the next quarter, whereas the lowest estimate is $467.53M.
A total of 7 analysts have provided revenue estimates for MD’s current fiscal year. The highest revenue estimate was $1.94B, while the lowest revenue estimate was $1.89B, resulting in an average revenue estimate of $1.91B. In the same quarter a year ago, actual revenue was $2.01BBased on 7 analysts’ estimates, the company’s revenue will be $1.96B in the next fiscal year. The high estimate is $2.02B and the low estimate is $1.88B.
